Among established transformed clones, 11 of 27 exposed to SW480 and 5/9 (exposed to the serum of the patient with cancer) had the K-ras mutation as proven by PCR utilizing primers specific for amplifying human K-ras. The gene discussed is KRAS; the disease is cancer.